Both IDR models in this study involve the inhibition of Kin (Table 2) The IDR model for biomarker described a delayed onset of cMet phosphorylation following PF02341066 administration, suggesting a rate-limiting distribution from plasma into tumor. This evidence concerns the gene MET and neoplasm.